- Corporate Officers - B
- Butler John P.
Insider Trading History of Butler John P.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Butler John P. since 2014.
This trader's CIK number is 1591467.
At the time of last reporting, Butler John P. was the CEO and President of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
Note that in the past
Butler John P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Relypsa Inc (RLYP) by Butler John P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | RLYP | 0 | $0 | 1,013 | $19,570 | 0 | $0 |
| 2015 | RLYP | 0 | $0 | 1,100 | $38,086 | 0 | $0 |
Yearly summary of insider trading at Akebia Therapeutics, Inc. (AKBA) by Butler John P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AKBA | 0 | $0 | 46,409 | $84,928 | 0 | $0 |
| 2024 | AKBA | 0 | $0 | 130,792 | $209,035 | 0 | $0 |
| 2023 | AKBA | 0 | $0 | 130,500 | $112,067 | 0 | $0 |
| 2022 | AKBA | 0 | $0 | 79,026 | $171,164 | 0 | $0 |
| 2021 | AKBA | 0 | $0 | 54,099 | $183,736 | 0 | $0 |
| 2019 | AKBA | 50,000 | $172,000 | 0 | $0 | 287,000 | $134,890 |
| 2018 | AKBA | 0 | $0 | 0 | $0 | 100,000 | $47,000 |
| 2017 | AKBA | 0 | $0 | 0 | $0 | 20,000 | $9,400 |
| 2016 | AKBA | 0 | $0 | 0 | $0 | 25,000 | $11,750 |
| 2015 | AKBA | 0 | $0 | 0 | $0 | 150,000 | $70,500 |
| 2014 | AKBA | 17,850 | $280,574 | 0 | $0 | 30,500 | $14,335 |
Yearly summary of insider trading at Zynerba Pharmaceuticals, Inc. (ZYNE) by Butler John P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ZYNE | 0 | $0 | 115 | $40 | 0 | $0 |
| 2022 | ZYNE | 0 | $0 | 53 | $53 | 0 | $0 |
| 2018 | ZYNE | 5,000 | $32,155 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Butler John P.:
1. Relypsa Inc (RLYP)
2. Akebia Therapeutics, Inc. (AKBA)
3. Zynerba Pharmaceuticals, Inc. (ZYNE)
Table 1. Insider trading of Relypsa Inc (RLYP) by Butler John P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-07 | RLYP | Sale | 1,013 | 19.32 | 19,570 |
| 2015-06-11 | RLYP | Sale | 1,100 | 34.62 | 38,086 |
Table 2. Insider trading of Akebia Therapeutics, Inc. (AKBA) by Butler John P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-03 | AKBA | Sale | 46,409 | 1.83 | 84,928 |
| 2024-02-29 | AKBA | Sale | 46,570 | 1.58 | 73,580 |
| 2024-02-27 | AKBA | Sale | 37,733 | 1.52 | 57,354 |
| 2024-02-01 | AKBA | Sale | 46,489 | 1.68 | 78,101 |
| 2023-03-01 | AKBA | Sale | 91,868 | .88 | 80,660 |
| 2023-02-27 | AKBA | Sale | 38,632 | .81 | 31,407 |
| 2022-02-28 | AKBA | Sale | 25,053 | 2.15 | 53,989 |
| 2022-03-01 | AKBA | Sale | 53,973 | 2.17 | 117,175 |
| 2021-04-01 | AKBA | Sale | 4,109 | 3.40 | 13,970 |
| 2021-03-01 | AKBA | Sale | 49,990 | 3.40 | 169,766 |
| 2019-11-20 | AKBA | Buy | 50,000 | 3.44 | 172,000 |
| 2019-06-03 | AKBA | Option Ex | 287,000 | .47 | 134,890 |
| 2018-07-11 | AKBA | Option Ex | 100,000 | .47 | 47,000 |
| 2017-01-19 | AKBA | Option Ex | 20,000 | .47 | 9,400 |
| 2016-01-15 | AKBA | Option Ex | 25,000 | .47 | 11,750 |
| 2015-05-26 | AKBA | Option Ex | 50,000 | .47 | 23,500 |
| 2015-03-09 | AKBA | Option Ex | 100,000 | .47 | 47,000 |
| 2014-12-29 | AKBA | Buy | 1,000 | 11.57 | 11,567 |
| 2014-12-22 | AKBA | Buy | 1,000 | 11.92 | 11,916 |
| 2014-12-15 | AKBA | Buy | 1,000 | 11.34 | 11,336 |
| 2014-11-12 | AKBA | Buy | 1,000 | 10.30 | 10,305 |
| 2014-11-11 | AKBA | Option Ex | 30,500 | .47 | 14,335 |
| 2014-03-25 | AKBA | Buy | 13,850 | 17.00 | 235,450 |
Table 3. Insider trading of Zynerba Pharmaceuticals, Inc. (ZYNE) by Butler John P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-14 | ZYNE | Sale | 115 | .35 | 40 |
| 2022-06-14 | ZYNE | Sale | 53 | 1.01 | 53 |
| 2018-08-22 | ZYNE | Buy | 5,000 | 6.43 | 32,155 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Butler John P.
(CEO and President of Akebia Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.